Rothschild & Co Redburn Forecasts Strong Price Appreciation for Albemarle (NYSE:ALB) Stock

Albemarle (NYSE:ALB - Get Free Report) had its price target upped by investment analysts at Rothschild & Co Redburn from $135.00 to $158.00 in a note issued to investors on Thursday,MarketScreener reports. The firm presently has a "buy" rating on the specialty chemicals company's stock. Rothschild & Co Redburn's target price would indicate a potential upside of 29.39% from the stock's current price.

• 3 Signals Pointing to a Turnaround for Albemarle

Several other research analysts have also weighed in on the company. Wells Fargo & Company lifted their price objective on Albemarle from $90.00 to $100.00 and gave the stock an "equal weight" rating in a research report on Tuesday, November 11th. Zacks Research cut Albemarle from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, November 5th. Mizuho boosted their price target on Albemarle from $92.00 to $110.00 and gave the company a "neutral" rating in a research note on Thursday, November 13th. Truist Financial increased their price target on Albemarle from $87.00 to $91.00 and gave the stock a "hold" rating in a report on Friday, November 7th. Finally, Royal Bank Of Canada raised their price objective on shares of Albemarle from $117.00 to $120.00 and gave the stock an "outperform" rating in a research report on Monday, November 10th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, eighteen have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $104.21.

Get Our Latest Stock Analysis on ALB

Albemarle Stock Down 3.5%

• 5 Surprising Stocks Set to Benefit From a Future Robotics Boom

Shares of NYSE ALB opened at $122.11 on Thursday. The company's 50 day moving average price is $102.57 and its 200-day moving average price is $82.01. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.51 and a current ratio of 2.27. Albemarle has a 52-week low of $49.43 and a 52-week high of $132.90. The company has a market capitalization of $14.37 billion, a P/E ratio of -76.61 and a beta of 1.43.

Albemarle (NYSE:ALB - Get Free Report) last posted its quarterly earnings data on Wednesday, November 5th. The specialty chemicals company reported ($0.19) earnings per share for the quarter, topping the consensus estimate of ($0.92) by $0.73. The company had revenue of $1.31 billion during the quarter, compared to analysts' expectations of $1.27 billion. Albemarle had a negative net margin of 0.43% and a positive return on equity of 0.10%. Albemarle's revenue for the quarter was down 3.5% compared to the same quarter last year. During the same period in the prior year, the company posted ($1.55) earnings per share. Equities analysts forecast that Albemarle will post -0.04 earnings per share for the current year.

Institutional Trading of Albemarle

• 5 EV Battery and Lithium Stocks Charging the Future

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Manning & Napier Advisors LLC bought a new position in shares of Albemarle in the third quarter valued at approximately $138,723,000. ProShare Advisors LLC grew its holdings in Albemarle by 48.5% during the second quarter. ProShare Advisors LLC now owns 2,870,110 shares of the specialty chemicals company's stock worth $179,870,000 after buying an additional 937,538 shares in the last quarter. AQR Capital Management LLC raised its position in Albemarle by 22,047.4% in the 2nd quarter. AQR Capital Management LLC now owns 713,812 shares of the specialty chemicals company's stock valued at $44,613,000 after buying an additional 710,589 shares during the last quarter. Samlyn Capital LLC purchased a new stake in Albemarle in the 3rd quarter valued at $47,088,000. Finally, FengHe Fund Management Pte. Ltd. bought a new position in Albemarle during the 2nd quarter valued at $32,903,000. 92.87% of the stock is owned by institutional investors.

Albemarle Company Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

Further Reading

• Five stocks we like better than Albemarle
• The 3 Best Blue-Chip Stocks to Buy Now
• Battle of the Big-Upside Tech Names: HUBS vs. NBIS vs. TEAM
• What Makes a Stock a Good Dividend Stock?
• MongoDB Just Posted a Blowout Quarter—But Is It Too Hot to Touch?
• Best ESG Stocks: 11 Best Stocks for ESG Investing
• 3 Stocks Poised to Benefit From Google’s AI Breakthough

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Albemarle Right Now?

Before you consider Albemarle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.

While Albemarle currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here